<i>BRCA1</i>-Associated Breast Cancers Present Differently From <i>BRCA2</i>-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study

Abstract

Screening results were somewhat worse in BRCA1 mutation carriers, but 6-year survival was high in all risk groups.